During obesity-associated metabolic disease, intestinal IgA+ ASCs, potentially targeting commensal microorganisms or self-antigens (e.g., through antigenic mimicry), might traffic to inflamed metabolic tissues in an attempt to mitigate inflammation. This evidence concerns the gene CD79A and obesity disorder.